Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein PIGBOS1 is a small, 54-amino acid microprotein localized to the mitochondrial outer membrane, where it plays a pivotal role in regulating the endoplasmic reticulum (ER) unfolded protein response (UPR)[1][2][7]. PIGBOS1 interacts specifically with the ER-localized protein CLCC1 at mitochondria–ER contact sites, and its presence modulates cellular sensitivity to ER stress[1]. Loss of PIGBOS1 leads to heightened UPR activation and increased apoptosis, suggesting its importance for cell survival and homeostasis[1][2]. This protein is not classified as a therapeutic target or a member of traditional druggable protein families; instead, it represents a newly-appreciated class of microproteins essential for inter-organelle communication, but no clinical drugs, biomarker applications, or safety challenges are documented for this target at present[1][2][3][7].
Not applicable (no known drugs interacting directly with PIGBOS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein PIGBOS1 (PIGBOS1).